Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03786224 · ClinicalTrials.gov registry record · NA
Pilot Trial of Contingency Management for Long-Term Cannabis Abstinence
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03786224: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03786224 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03786224, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is a critically important first-of-its-kind investigation of the potential research utility of using contingency management to examine long-term changes in cannabis use with six months of abstinence. These pilot data will inform a later trial which will focus on testing the longitudinal relationships between adolescent cognition and cannabis use, questions of high and growing public health significance given adolescents' increased access to cannabis with legalization.
Interventions
- BEHAVIORAL Contingency Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2019-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03786224
The ClinicalTrials.gov registry entry for NCT03786224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contingency Management is the first listed.
NCT03786224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03786224 about?
NCT03786224 is a clinical study titled "Pilot Trial of Contingency Management for Long-Term Cannabis Abstinence". This study is a critically important first-of-its-kind investigation of the potential research utility of using contingency management to examine long-term changes in cannabis use with six months of abstinence. These pilot data will inform a later trial which will focus on testing the longitudinal r...
What is the current status of trial NCT03786224?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-07-01. Estimated completion is 2019-12-06.
What interventions are being tested in trial NCT03786224?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03786224?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.